Schedule 13G ownership disclosure

ITEOS THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 46565G104

Event date: 2025-05-13

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 3,826,692.00 · Class: 9.99%

  • KEVIN TANG

    Shares: 3,826,692.00 · Class: 9.99%

  • TANG CAPITAL PARTNERS, LP

    Shares: 2,618,219.00 · Class: 6.84%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 1,208,473.00 · Class: 3.15%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 0.00 · Class: 0.0%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-007875
Form type
SCHEDULE 13G
Filer
TANG CAPITAL MANAGEMENT LLC
CIK
CIK 1232621
Filed
May 15, 2025
Reporting period
May 13, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub